Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications

Ítems similars

• Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
  per: Laddha Ankit P.
  Publicat: (2021)
• Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
  per: Suryavanshi Sachin Vilas
  Publicat: (2021)
• Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
  per: Parkar Nishad
  Publicat: (2014)
• Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications
  per: Adki Kaveri M.
  Publicat: (2023)
• Therapeutic Potential of Beta-Caryophyllene Combined with L-Arginine in the Management of Diabetic Complications
  per: Kumawat Vivek S.
  Publicat: (2023)